Announcements Trials

Browse Landscape

Phase

Phase NA 4 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Breast Neoplasms 1

Interventions

pembrolizumab 514 Specimen Handling 384 Carboplatin 372 Magnetic Resonance Spectroscopy 337 Cisplatin 327 Nivolumab 301 Cyclophosphamide 297 Radiotherapy 255 Paclitaxel 255 Biopsy 237 Gemcitabine 229 Bevacizumab 212 Dexamethasone 168 durvalumab 162 Oxaliplatin 159 Capecitabine 154 Rituximab 153 Fluorouracil 148 venetoclax 143 atezolizumab 142 Drug Therapy 140 Docetaxel 140 Etoposide 139 Doxorubicin 132 Ipilimumab 124 Lenalidomide 119 Radiosurgery 118 Prednisone 116 Leucovorin 112 fludarabine 109

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Diet, Mediterranean × 1 year × Clear all

NCT07406789 2026-02-12

LUMInova

TNC Nutrición Terapéutica S.L.

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡